Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China
Jing Xu(Fuyang City People's Hospital), Changlin Mei(Xi'an Polytechnic University), Yixiang Zhang(Fujian Medical University), Lining Wang(First Hospital of China Medical University), Wang Mei(Peking University), Jianghua Chen(Xishuangbanna Tropical Botanical Garden), Yaping Fan, Guohua Ding(Wuhan University), Zhaohui Ni(Renji Hospital), Xiangmei Chen(State Administration of Traditional Chinese Medicine of the People's Republic of China), Aiping Zhang(Yangzhou University), Yuan Fa-huan(Army Medical University), Xueqing Yu(Guangdong Provincial People's Hospital)
Cited by 24
Related Papers
Kruppel-Like Factor 15 Modulates Renal Interstitial Fibrosis by ERK/MAPK and JNK/MAPK Pathways Regulation
|Kidney & Blood Pressure Research|2013|1k
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
|International Journal of Biological Sciences|2022|350
The 2.5 Å Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD<sup>+</sup>) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition
|Journal of Medicinal Chemistry|2013|218
Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
|American Journal of Kidney Diseases|2010|202
A Multicenter Application and Evaluation of the Oxford Classification of IgA Nephropathy in Adult Chinese Patients
|American Journal of Kidney Diseases|2012|157